New nanomaterials for consolidating stone
The SWOT analysis of Medical Device Industry shows that its major strengths are – (a) Well developed Microelectronic, Telecommunication, Software and Precision Engineering Industry, (b) Ability to attract foreign investments and (c) Ability to handle low value large volume production as per global quality standards.
The major weaknesses are – (a) Low per capita expenditure on health care & low health insurance, (b) Lack of adequate and trained manpower, (c) Lack of incubation and suitable ecosystem, (d) Lack of regulation/standards etc.
i EXECUTIVE SUMMARY The Indian pharmaceutical Industry has witnessed a robust growth of around 14% since the beginning of the 11 th Plan in 2007 from about Rs 71000 crores to over Rs1 lac crores in 2009‐10 comprising some Rs62,055 crores of domestic market and exports of over Rs 42,154 crores.
This also amounts to around 20% of total volume of global generics.
The major therapeutic categories of export are anti infective, anti asthmatic and anti hypertensive.
The Department of Pharmaceuticals has a Vision for the development of the Indian Pharmaceutical Industry.
The 12 th Plan Document highlights the vital role Drug price play in access to essential medicines across the world.
While it is a fact that the drugs manufactured in India are considered to be amongst the lowest priced internationally, still, a vast section of Indian population is not in a position to access the needed health care as well as the medicines due to various reasons of access and affordability.
• Upgradation of SMEs to WHO‐GMP and training of professionals therein. There is need to develop world class support infrastructure both for production and research.The Medical Device Industry is also proposed to be supported through the development of a Medical Devices Park in Ahmedabad, Gujarat.